Edison Investment Research is terminating coverage on PB Holding (PBH). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Industrials |
Flash note
Financials |
Flash note
Financials |
Flash note
Financials |
Flash note
Forecast net debt (€m)
N/A
Forecast gearing ratio (%)
N/A
% | 1M | 3M | 12M |
---|---|---|---|
Actual | (3.4) | 6.4 | (6.9) |
Relative | (4.6) | 0.7 | (24.0) |
52 week high/low | €3.2/€2.7 |
Edison Investment Research is terminating coverage on Oxford Cannabinoid Technologies (OCTP), Britvic (BVIC), Ultimovacs (ULTI), DFR Gold (DFR), The Merchants Trust (MRCH), PB Holding (PBH) and Biodexa Pharmaceuticals (BDRX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Previously published reports can still be accessed via our website.
Y/E Dec | Revenue (€m) | EBITDA (€m) | PBT (€m) | EPS (c) | P/E (x) | P/CF (x) |
---|---|---|---|---|---|---|
2022A | 0.5 | 0.6 | 1.4 | 11.0 | 27.8 | N/A |
2023A | 0.3 | (0.3) | 0.6 | (46.0) | N/A | N/A |
2024E | N/A | N/A | N/A | N/A | N/A | N/A |
2025E | N/A | N/A | N/A | N/A | N/A | N/A |